Xegen is a bioinformatics company specialized in Next Generation Sequencing (NGS) data analysis.
We provide support for our customers or partners in their NGS data processing issues, through specific, automated, high added value bioinformatics analyzes.
Xegen is developing Polypheme a bioinformatics suite dedicated to complex genes analysis (polymorphisms detection or allelic types).
Polypheme analysis includes in particular HLA Typing, classic (HLA-A, -B, -C, DRB1, DQB1) and not classic genes (HLA-E, -F, -G, -H). Polypheme is also used to discover new alleles.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 15 Rue Dominique Piazza, Gemenos,13420,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- xegen.eu
- Keywords
- Bioinformatics, Genomics, Typing, HLA, Diagnostics, NGS data analysis, Personalized Medicine.
- HQ
- GEMENOS
Xegen Questions
Xegen's website is xegen.eu
Xegen's LinkedIn profile is https://fr.linkedin.com/company/xegen
Xegen has
3 employees.
View email and phone details for 3
employees at Xegen.
Xegen's industry is
Biotechnology Research
Xegen's top competitors are
Diamidex,
Vect-Horus,
Oz Biosciences,
Genxmap,
Biocellvia,
Calysens,
Bilhi Genetics,
C4diagnostics,
Theranyx,
Firalis Molecular Precision.
Xegen's categories are Biotechnology Research
Xegen's founding year is 2012
